Open Source Drug Discovery

Open Source Drug Discovery

Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

118


Total Open
Publications

72


Total
Citations

1.7K


Open Access
Percentage

61%


Total
Publications

118


Total Open
Publications

72


Total
Citations

1.7K

Wikipedia

Website

download

Breakdown

27% 31% 3% 39%

Publisher Open

27%

Both

31%

Other Platform Open

3%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

41%OA Journal

OA Journal 41%

28

Hybrid 34%

23

No Guarantees 25%

17

Other Platform Open

Domain 88%

35

Public 20%

8

Institution 13%

5

Other Internet 13%

5

Preprint 5%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
34
Europe PMC
Domain
26
Semantic Scholar
Public
8
DOI
Other Internet
4
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
University Computing Centre - Hrčak Portal of scientific journals of Croatia
Other Internet
2
University College London - UCL Discovery
Institution
2
Preprints
Preprint
2
Unknown Repository
Other Internet
1
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
1
1 / 2

Data updated 7 October 2024

Share

Share

Share